Title (en)

MYCOPLASMA HYOPNEUMONIAE ANTIGEN AND USES THEREFOR

Publication

EP 0283840 A3 19890809 (EN)

Application

EP 88103590 A 19880308

Priority

US 3013087 A 19870326

Abstract (en)

[origin: EP0283840A2] A vaccine for M. hyopneumoniae is comprised of M. hyopneumoniae antigen(s), or fragments, which lack immunosuppressive activity.

IPC 1-7

A61K 39/02

IPC 8 full level

A61K 39/00 (2006.01); C07K 14/30 (2006.01)

CPC (source: EP)

C07K 14/30 (2013.01); A61K 39/00 (2013.01)

Citation (search report)

• [X] WO 8600019 A1 19860103 - CENTRE NAT RECH SCIENT [FR], et al
• [X] EP 0196215 A1 19861001 - BIOGEN NV [NL]
• [A] EP 0156633 A1 19851002 - EISAI CO LTD [JP]
• CHEMICAL ABSTRACTS, vol. 94, no. 9, 02 March 1981, Columbus, OH (US); J. NICOLET et al., p. 543, no. 63478y#
• [A] CHEMICAL ABSTRACTS, vol. 94, no. 9, 2nd March 1981, page 543, abstract no. 63478y, Columbus, Ohio, US; J. NICOLET et al.: "Tween 20 soluble proteins of Mycoplasma hyopneumoniae as antigen for an enzyme-linked immunosorbent assay", & RES. VET. SCI. 1980, 29(3), 305-9
• [AD] AMERICAN JOURNAL VETERINARY RESEARCH, vol. 45, no. 10, October 1984, pages 1899-1905; R.F. ROSS et al.: "Characteristics of protective activity of Mycoplasma hyopneumoniae vaccine"

Designated contracting state (EPC)

AT BE CH DE ES FR GB GR IT LI LU NL SE

DOCDB simple family (publication)

EP 0283840 A2 19880928; EP 0283840 A3 19890809; CA 1321142 C 19930810; CN 88101554 A 19881102; DK 167488 A 19880927; DK 167488 D0 19880325; HU 203672 B 19910930; HU T46237 A 19881028; IE 61626 B1 19941116; IE 880779 L 19880926; JP S63258427 A 19881025; PT 87041 A 19890330

DOCDB simple family (application)

EP 88103590 A 19880308; CA 562476 A 19880325; CN 88101554 A 19880325; DK 167488 A 19880325; HU 152588 A 19880325; IE 77988 A 19880316; JP 6375588 A 19880318; PT 8704188 A 19880322